サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1362886

血栓管理デバイスの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2023年～2030年

Clot Management Devices Market Size, Share & Trends Analysis Report By Product (Neurovascular Embolectomy Devices, Percutaneous Thrombectomy Devices), By End-use (Diagnostic Centers, Hospitals), By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 100 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
血栓管理デバイスの市場規模、シェア、動向分析レポート：製品別、最終用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年09月04日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血栓管理デバイス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、血栓管理デバイスの世界市場規模は2030年までに25億3,000万米ドルに達し、予測期間中にCAGR 5.0％で進展すると予測されています。

市場成長の原動力は、心血管疾患の有病率の増加、老人人口の増加、医療技術の進歩などいくつかの要因です。また、深刻な健康合併症の予防における効果的な血栓管理の利点に関する医療専門家や患者の意識の高まりも、これらの機器の需要を後押ししています。

心血管疾患の罹患率が上昇していることも、市場の需要に拍車をかけています。人口の高齢化に伴い、血液凝固の形成に関連する危険因子が増加し、効果的なソリューションの必要性が浮き彫りになっています。医療プロバイダーは、CVDの負担増に対処し、血液凝固に関連するリスクを軽減するために、先進的なデバイスを求めています。血栓管理デバイスの技術的進歩も市場成長の原動力となっています。カテーテル、フィルター、ステントなどの技術革新は、凝血塊の回収・溶解能力を高めるために開発されています。この分野における最先端技術の継続的開拓が採用率を押し上げ、市場成長を後押ししています。

COVID-19の大流行は、ウイルスに関連する血液凝固リスク増大に対する認識を高め、市場に強い影響を与えました。医療提供者は、重度の肺病変や血栓関連の合併症を持つCOVID-19患者の治療に血栓回収装置を利用することが増え、患者の転帰を改善しました。血栓管理の重要性に対する認識の高まりは、凝固関連合併症の予防と管理を優先する医療システムに長期的な効果をもたらすものと思われます。医療プロバイダーがパンデミックがもたらす課題に対処し、包括的な患者ケアを優先することで、市場は持続的な成長を遂げる見通しです。

血栓管理デバイス市場レポートハイライト

  • 製品別では、経皮的血栓除去装置が2022年に最大の売上シェアを占めました。これは、血栓を除去するための低侵襲手技に使用されるためであり、患者と医療提供者の両方にアピールします。このセグメントの優位性は、革新的なデバイスの開発や血栓除去における有効性の向上といった技術の進歩が、経皮的血栓除去デバイスの高い採用率と需要につながっていることにも起因しています。
  • 最終用途に基づき、血栓管理デバイス市場は診断センターと病院に分類されます。病院セグメントは2022年に最大の収益シェアを占めました。病院は、血栓管理を必要とする患者の一次診療所としての役割を果たし、初期評価、診断、治療勧告を行う。病院には医療機器を選択するための専門委員会やチームがあり、血栓管理機器にアクセスするためにバリューチェーンのさまざまな事業体と協力しています。
  • 北米地域は2022年に59.73%と最大の収益シェアを占め、市場を独占すると予想されています。北米は、病院、診療所、医療施設など、整備された高度な医療インフラを有しています。さらに、心血管疾患の有病率の上昇と高齢化が、北米の製品需要をさらに促進しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場動向と展望
  • 市場力学
    • 心血管疾患の有病率の増加
    • 医療技術の進歩
    • 効果的な血栓除去術/塞栓除去術装置に対する需要の増加
  • 市場抑制要因分析
    • 装置コストが高い
    • 認識とトレーニングが限られている
  • 事業環境分析
    • SWOT分析;要因別（政治・法律、経済・技術）
    • ポーターのファイブフォース分析
  • COVID-19感染症の影響分析

第4章 血栓管理デバイス市場：製品のセグメント分析

  • 血栓管理デバイス：市場シェア分析、2022年および2030年
  • 神経血管塞栓除去用デバイス
  • 塞栓除去用バルーンカテーテル
  • 経皮的血栓除去用デバイス
  • カテーテル指向性血栓溶解療法（CDT）デバイス
  • 下大静脈フィルター（IVCF）

第5章 血栓管理デバイス市場：最終用途のセグメント分析

  • 血栓管理デバイス：市場シェア分析、2022年および2030年
  • 診断センター
  • 病院

第6章 血栓管理デバイス市場：地域の分析

  • 地域別の血栓管理デバイス市場シェア、2022年および2030年
  • 北米
    • 北米の血栓管理デバイス市場、2018年から2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州の血栓管理デバイス市場、2018年から2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • アジア太平洋地域の血栓管理デバイス市場、2018～2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカの血栓管理デバイス市場、2018年から2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカの血栓管理デバイス市場、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業の分類
  • 戦略マッピング
  • 企業の市場シェア分析、2022年
  • 企業プロファイル・一覧表
    • Medtronic
    • Boston Scientific Corporation
    • iVascular SLU
    • Teleflex Inc
    • Edwards Lifesciences Corporation
    • LeMaitre Vascular, Inc
    • Vascular Solutions, Inc
    • Straub Medical AG
    • Cook Medical
    • DePuy Synthes
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 Global clot management devices market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Canada clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 UK clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 UK clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Germany clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 18 Germany clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 France clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 France clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Italy clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Spain clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Spain clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Denmark clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 26 Denmark clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Sweden clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Norway clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Norway clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Japan clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 35 Japan clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 36 China clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 37 China clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 India clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 39 India clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Australia clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 41 Australia clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Thailand clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 43 Thailand clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 South Korea clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 45 South Korea clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Latin America clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 48 Latin America clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 49 Brazil clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 50 Brazil clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 Mexico clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 52 Mexico clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Argentina clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 54 Argentina clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa clot management devices market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 South Africa clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 59 South Africa clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 UAE clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 63 UAE clot management devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait clot management devices market, by product, 2018 - 2030 (USD Million)
  • Table 65 Kuwait clot management devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain-based sizing & forecasting
  • FIG. 6 Market formulation & validation
  • FIG. 7 Clot management devices market segmentation
  • FIG. 8 Market snapshot, 2022
  • FIG. 9 Market trends & outlook
  • FIG. 10 Market driver relevance analysis (current & future impact)
  • FIG. 11 Market restraint relevance analysis (current & future impact)
  • FIG. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • FIG. 13 Porter's five forces analysis
  • FIG. 14 Market penetration & growth prospect mapping, 2022
  • FIG. 15 Global clot management devices market: Product movement analysis
  • FIG. 16 Global clot management devices market, for neurovascular embolectomy devices, 2018 - 2030 (USD Million)
  • FIG. 17 Global clot management devices market, for embolectomy balloon catheters, 2018 - 2030 (USD Million)
  • FIG. 18 Global clot management devices market, for percutaneous thrombectomy devices, 2018 - 2030 (USD Million)
  • FIG. 19 Global clot management devices market, for catheter-directed thrombolysis (CDT) devices, 2018 - 2030 (USD Million)
  • FIG. 20 Global clot management devices market, for inferior vena cava filters (IVCF), 2018 - 2030 (USD Million)
  • FIG. 21 Global clot management devices market: End user movement analysis
  • FIG. 22 Global clot management devices market, for diagnostic centers, 2018 - 2030 (USD Million)
  • FIG. 23 Global clot management devices market, for hospitals, 2018 - 2030 (USD Million)
  • FIG. 24 Regional marketplace: Key takeaways
  • FIG. 25 Regional outlook, 2022 & 2030
  • FIG. 26 Global clot management devices market: Regional movement analysis
  • FIG. 27 North America clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 28 U.S. clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 29 Canada clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 30 Europe clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 31 Germany clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 32 UK clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 33 France clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 34 Italy clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 35 Spain clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 36 Denmark clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 37 Sweden clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 38 Norway clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 39 Asia Pacific clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 40 Japan clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 41 China clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 42 India clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 43 Australia clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 44 South Korea clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 45 Thailand clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 46 Latin America clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 47 Brazil clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 48 Mexico clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 49 Argentina clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 50 Middle East and Africa clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 51 South Africa clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 52 Saudi Arabia clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 53 UAE clot management devices market, 2018 - 2030 (USD Million)
  • FIG. 54 Kuwait clot management devices market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-1-68038-201-3

Clot Management Devices Market Growth & Trends:

The global clot management devices market size is expected to reach USD 2.53 billion by 2030, advancing at a CAGR of 5.0% during the forecast period, according to a new report by Grand View Research, Inc.. The market growth is driven by several factors, including an increase in the prevalence of cardiovascular diseases, a rise in geriatric population, and advancements in medical technology. The demand for these devices is also fueled by the growth in awareness among healthcare professionals and patients regarding the benefits of effective clot management in preventing serious health complications.

The rising incidence of cardiovascular diseases has fueled market demand. As the population ages, the risk factors associated with blood coagulum formation increase, highlighting the need for effective solutions. Healthcare providers are seeking advanced devices to address the growing burden of CVDs and mitigate coagulum-related risks. Technological advancements in clot management devices have also driven market growth. Innovations such as catheters, filters, and stents are being developed to enhance coagulum retrieval and dissolution capabilities. Continued development of cutting-edge technologies in the field has boosted adoption rates and propelled market growth.

The COVID-19 pandemic strongly impacted the market by raising awareness of the increased blood coagulum risk associated with the virus. Healthcare providers have increasingly utilized clot retrieval devices to treat COVID-19 patients with severe lung involvement and clot-related complications, improving patient outcomes. Increased awareness of clot management's importance is poised to have long-lasting effects on healthcare systems prioritizing the prevention and management of coagulum-related complications. The market is poised to witness sustained growth as healthcare providers address challenges posed by the pandemic and prioritize comprehensive patient care.

Clot Management Devices Market Report Highlights:

  • Based on product, the percutaneous thrombectomy devices segment held the largest revenue share in 2022, as it is used in minimally invasive procedures for removing blood clots, which appeals to both patients and healthcare providers. The segment's dominance can also be attributed to advancements in technology, such as the development of innovative devices and improved efficacy in clot removal, leading to higher adoption rates and demand for percutaneous thrombectomy devices
  • Based on end-use, the market for clot management devices has been categorized into diagnostic centers and hospitals. The hospitals segment accounted for the largest revenue share in 2022. Hospitals serve as the primary point of care for patients requiring clot management, providing initial evaluation, diagnosis, and treatment recommendations. They have dedicated committees and teams for selecting medical devices and collaborating with different entities in the value chain to access clot management devices
  • The North American region accounted for the largest revenue share of 59.73% in 2022 and is expected to dominate the market. North America has a well-developed, advanced healthcare infrastructure, including hospitals, clinics, and medical facilities; additionally, the rising prevalence of cardiovascular diseases and an aging population further drive product demand in North America

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information Or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing Prevalence of cardiovascular diseases
    • 3.4.2. Advancements In Medical Technology
    • 3.4.3. Increasing Demand for Effective Thrombectomy/Embolectomy Devices
  • 3.5. Market Restraint Analysis
    • 3.5.1. High device cost
    • 3.5.2. Limited awareness and training
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.6.2. Porter's Five Forces Analysis
  • 3.7. COVID-19 Impact Analysis

Chapter 4. Clot Management Devices Market: Product Segment Analysis

  • 4.1. Clot Management Devices: Market Share Analysis, 2022 & 2030
  • 4.2. Neurovascular Embolectomy Devices
    • 4.2.1. Neurovascular Embolectomy Devices Market, 2018 - 2030 (USD Million)
  • 4.3. Embolectomy Balloon Catheters
    • 4.3.1. Embolectomy Balloon Catheters Market, 2018 - 2030 (USD Million)
  • 4.4. Percutaneous Thrombectomy Devices
    • 4.4.1. Percutaneous Thrombectomy Devices Market, 2018 - 2030 (USD Million)
    • 4.4.2. Aspiration Thrombectomy Devices
      • 4.4.2.1. Aspiration Thrombectomy Devices market, 2018 - 2030 (USD Million)
    • 4.4.3. Percutaneous Mechanical Thrombectomy Devices
      • 4.4.3.1. Percutaneous Mechanical Thrombectomy Devices market, 2018 - 2030 (USD Million)
  • 4.5. Catheter-Directed Thrombolysis (CDT) Devices
    • 4.5.1. Catheter-Directed Thrombolysis (CDT) Devices Market, 2018 - 2030 (USD Million)
  • 4.6. Inferior Vena Cava Filters (IVCF)
    • 4.6.1. Inferior Vena Cava Filters (IVCF) MARKET, 2018 - 2030 (USD MILLION)

Chapter 5. Clot Management Devices Market: End-Use Segment Analysis

  • 5.1. Clot Management Devices: Market Share Analysis, 2022 & 2030
  • 5.2. Diagnostic Centers
    • 5.2.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market, 2018 - 2030 (USD Million)

Chapter 6. Clot Management Devices Market; Regional Analysis

  • 6.1. Clot Management Devices Market Share By Region, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Clot Management Devices Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Clot Management Devices Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Clot Management Devices Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Mexico Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Argentina Clot Management Devices Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Clot Management Devices Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Clot Management Devices Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Medtronic
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Boston Scientific Corporation
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. iVascular SLU
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Teleflex Inc
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Edwards Lifesciences Corporation
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. LeMaitre Vascular, Inc
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. Vascular Solutions, Inc
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Straub Medical AG
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Cook Medical
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. DePuy Synthes
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives